Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
General Internal Medicine
•
Hematology
•
Sickle Cell
•
Benign Hematology
Would you start a patient with sickle cell disease and COVID-19 on prophylactic anticoagulation?
Related Questions
Would you consider continuing or re-trialing hydroxyurea for sickle cell patients after development of a leg ulcer?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
Is there any indication for hydroxyurea in patients with sickle cell trait?
Is there specific data on using luspatercept for sickle beta+ thalassemia with transfusion-dependent anemia?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
How do you manage arthritis resulting from deferiprone in transfusion dependent thalassemia?
Can lupus anticoagulant be positive despite a normal aPTT?
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
What are your top takeaways in Classical Hematology from ASH 2024?
